Bifido Co Ltd
Bifido Co Ltd's capital structure is characterized by a debt-to-equity ratio of 0.27, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 2.55, suggesting it can cover its short-term obligations. However, the company's cash and equivalents are negative at -370 KRW, and its free cash flow is negative at -5.48 billion KRW, indicating a cash outflow from operations after capital expenditures. Profitability metrics show a mixed picture. The company reported a net loss of 192.74 million KRW and an operating income of 1.4 billion KRW. Return on equity (ROE) is negative at -0.42%, and return on assets (ROA) is also negative at -0.31%. These figures are below the industry median for ROE and ROA, which are typically positive for companies in the Food Processing industry. The company's revenue is primarily concentrated in its domestic and overseas markets, with no specific segment breakdown provided. The lack of detailed segment data limits the ability to assess geographic exposure and revenue concentration. However, the company's operations span multiple product lines, including functional health foods, pet feed, and cosmetics. Looking at the growth trajectory, the company's revenue is expected to increase from 19.68 billion KRW to 33.9 billion KRW, representing a significant growth rate. Analyst estimates suggest a mean revenue estimate of 33.9 billion KRW, with a mean EBIT estimate of 10.1 billion KRW. This indicates a potential improvement in profitability and operational efficiency. Risk factors include a negative net cash position and a negative free cash flow, which could impact the company's ability to fund operations and investments. The company's dilution risk is assessed as low, with no significant dilution potential identified. However, the negative free cash flow and capital expenditures of -7.24 billion KRW suggest the company may need to seek additional financing in the near term. Recent events include the publication of the latest financial snapshot and analyst estimates. The company's financial performance and outlook are being closely monitored by analysts, with expectations for improved revenue and EBIT in the upcoming fiscal year.
Business. Bifido Co Ltd is a Korea-based company engaged in the manufacture and sale of functional health foods, including probiotic raw materials and finished products based on bifidobacteria, supplementary feed for pets, and cosmetics such as creams and serums.
Classification. Bifido Co Ltd is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry with a confidence level of 0.92.
- Bifido Co Ltd has a conservative debt-to-equity ratio of 0.27, indicating a relatively low leverage position.
- The company reported a net loss of 192.74 million KRW and a negative ROE of -0.42%, which are below industry medians.
- Analysts expect a significant increase in revenue to 33.9 billion KRW, with a mean EBIT estimate of 10.1 billion KRW.
- The company's liquidity is assessed as medium, with a current ratio of 2.55, but it has a negative cash and equivalents position.
- The company's risk assessment highlights a negative net cash position and a negative free cash flow, which could impact its financial stability.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.